Table Of Contents

1. Introduction 19
1.1. Objectives Of The Study 19
1.2. Market Definition 19
1.3. Overview Of Europe Exoskeleton Market 19
1.4. Currency And Pricing 20
1.5. Limitation 20
1.6. Markets Covered 21
2. Market Segmentation 23
2.1. Markets Covered 23
2.2. Geographic Scope 24
2.3. Years Considered For The Study 25
2.4. Currency And Pricing 25
2.5. Research Methodology 26
2.6. Primary Interviews With Key Opinion Leaders 29
2.7. Secondary Sources 30
2.8. Assumptions 30
3. Market Overview 31
3.1. Drivers 33
3.1.1. Growing Geriatric Population 33
3.1.2. Advent Of Robotic Technologies 34
3.1.3. Increased Investment Towards Exoskeleton Technology 35
3.2. Restraints 36
3.2.1. High Equipment Cost 36
3.3. Opportunity 37
3.3.1. Increasing Fda Approval And Clearance 37
3.3.2. Rising Acceptance Of Human Augmentation In Industrial And Military Sectors 37
3.4. Challenges 38
3.4.1. Issue Involved In Reimbursement Policies 38
4. Executive Summary 39
5. Premium Insights 41
6. Europe Exoskeleton Market, By Component 44
6.1. Overview 45
6.2. Hardware 48
6.2.1. Sensors 49
6.2.1.1. Accelerometer 49
6.2.1.2. Gyroscope 49
6.2.1.3. Tilt Sensor 49
6.2.1.4. Microphones 49
6.2.1.5. Position Sensors 50
6.2.1.6. Force Sensors 50
6.2.1.7. Others 50
6.2.2. Power Source 51
6.2.3. Actuator 51
6.2.3.1. Electrical 51
6.2.3.2. Piezoelectric 51
6.2.3.3. Pneumatic 52
6.2.3.4. Hydraulic 52
6.2.3.5. Others 52
6.2.4. Control System/ Controller 53
6.2.5. Others 53
6.3. Software 54
7. Europe Exoskeleton Market, By Mobility 55
7.1. Overview 56
7.2. Stationary 58
7.3. Mobile 59
8. Europe Exoskeleton Market, By Type 60
8.1. Overview 61
8.2. Powered 63
8.3. Passive 64
9. Europe Exoskeleton Market, By Body Parts 65
9.1. Overview 66
9.2. Upper Extremities 68
9.3. Lower Extremities 69
9.4. Full Body 70
10. Europe Exoskeleton Market, By End User 71
10.1. Overview 72
10.2. Healthcare 74
10.2.1. Rehabilitation 75
10.2.2. Elderly Care 75
10.3. Defense/Military 76
10.4. Industrial 77
11. Europe Exoskeleton Market By Geography 78
11.1. Europe 78
11.1.1. Germany 90
11.1.2. France 95
11.1.3. U.K. 100
11.1.4. Italy 104
11.1.5. Spain 108
11.1.6. Switzerland 112
11.1.7. Netherlands 117
11.1.8. Turkey 122
11.1.9. Belgium 127
11.1.10. Russia 132
11.1.11. Rest Of Europe 137
12. Europe Exoskeleton Market, Company Landscape 138
12.1. Company Share Analysis; Europe 138
13. Company Profiles 139
13.1. Atoun Inc. 139
13.1.1. Company Overview 139
13.1.2. Atoun Inc. ; Company Snapshot 139
13.1.3. Product Portfolio 140
13.1.4. Recent Developments 140
13.2. Suit X 141
13.2.1. Company Overview 141
13.2.2. Suitx; Company Snapshot 141
13.2.3. Product Portfolio 142
13.2.4. Recent Developments 142
13.3. Hocoma 143
13.3.1. Company Overview 143
13.3.2. Hocoma; Company Snapshot 143
13.3.3. Product Portfolio 144
13.3.4. Recent Developments 144
13.4. Rex Bionics Ltd 145
13.4.1. Company Overview 145
13.4.2. Rex Bionics Ltd; Company Snapshot 145
13.4.3. Product Portfolio 146
13.4.4. Recent Developments 146
13.5. Rewalk Robotics 147
13.5.1. Company Overview 147
13.5.2. Rewalk Robotics; Revenue Analysis 147
13.5.3. Product Portfolio 148
13.5.4. Recent Developments 148
13.6. Rb3D 149
13.6.1. Company Overview 149
13.6.2. Rb3D; Company Snapshot 149
13.6.3. Product Portfolio 150
13.6.4. Recent Developments 150
13.7. Raytheon Company 151
13.7.1. Company Overview 151
13.7.2. Raytheon Company ; Revenue Analysis 151
13.7.3. Product Portfolio 152
13.7.4. Recent Developments 152
13.8. Parker Hannifin Corp 153
13.8.1. Company Overview 153
13.8.2. Parker Hannifin Corp; Revenue Analysis 153
13.8.3. Product Portfolio 154
13.8.4. Recent Developments 154
13.9. Ottobock 155
13.9.1. Company Overview 155
13.9.2. Ottobock; Company Snapshot 155
13.9.3. Product Portfolio 156
13.9.4. Recent Developments 156
13.10. Fourier Intelligence Co., Ltd. 157
13.10.1. Company Overview 157
13.10.2. Fourier Intelligence Co., Ltd.; Company Snapshot 157
13.10.3. Product Portfolio 158
13.10.4. Recent Developments 158
?
13.11. Esco Bionics 159
13.11.1. Company Overview 159
13.11.2. Esco Bionics ; Revenue Analysis 159
13.11.3. Product Portfolio 160
13.11.4. Recent Developments 160
13.12. B-Temia 161
13.12.1. Company Overview 161
13.12.2. B-Temia ;Company Snapshot 161
13.12.3. Product Portfolio 162
13.12.4. Recent Developments 162
13.13. Focal Meditech Bv 163
13.13.1. Company Overview 163
13.13.2. Focal Meditech Bv ; Company Snapshot 163
13.13.3. Product Portfolio 164
13.13.4. Recent Developments 165
13.14. Cyberdyne, Inc. 166
13.14.1. Company Overview 166
13.14.2. Cyberdyne,Inc. ; Revenue Analysis 166
13.14.3. Product Portfolio 167
13.14.4. Recent Developments 167
13.15. Bionik Laboratories Corp. 168
13.15.1. Company Overview 168
13.15.2. Bionik Laboratories Corp. ; Revenue Analysis 168
13.15.3. Product Portfolio 169
13.15.4. Recent Developments 169
13.16. Lockheed Martin Corporation 170
13.16.1. Company Overview 170
13.16.2. Lockheed Martin Corporation; Revenue Analysis 170
13.16.3. Product Portfolio 171
13.16.4. Recent Developments 172
13.17. Dih Technologies Corporation 173
13.17.1. Company Overview 173
13.17.2. Dih Technologies Corporation; Company Snapshot 173
13.17.3. Product Portfolio 174
13.17.4. Recent Developments 174
13.18. Gogoa 175
13.18.1. Company Overview 175
13.18.2. Gogoa; Revenue Analysis 175
13.18.3. Product Portfolio 176
13.18.4. Recent Developments 176
13.19. Honda Motor Co., Ltd. 177
13.19.1. Company Overview 177
13.19.2. Honda Motor Co., Ltd.; Revenue Analysis 177
13.19.3. Product Portfolio 178
13.19.4. Recent Developments 178
13.20. Exhauss 179
13.20.1. Company Overview 179
13.20.2. Exhauss; Company Snapshot 179
13.20.3. Product Portfolio 180
13.20.4. Recent Developments 180
14. Related Reports 181